NanoViricides (NNVC) Stock Chart & Stock Price History $1.60 +0.21 (+14.70%) Closing price 07/14/2025 04:00 PM EasternExtended Trading$1.60 0.00 (0.00%) As of 07/14/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NanoViricides Stock Price Performance The NanoViricides (NNVC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 10.61%, with a year-to-date return of 11.89%. In the past month, the stock has increased 5.96%, reflecting recent market activity. As of the latest close, NanoViricides traded at $1.60 with a market cap of $25.72 million and volume of 632,344 shares. Receive NNVC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+13.48%1 Month Performance+5.96%3 Month Performance+20.30%Year-To-Date Performance+11.89%1 Year Performance-10.61% NNVC Stock Chart for Tuesday, July, 15, 2025 NNVC Chart by TradingView NanoViricides Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/14/2025$1.40$1.60+14.70%$1.61$1.41632,344 shs$25.72 million07/11/2025$1.41$1.40-1.06%$1.40$1.37121,721 shs$22.42 million07/10/2025$1.40$1.41+0.71%$1.42$1.36109,085 shs$22.66 million07/09/2025$1.39$1.40+0.72%$1.42$1.34172,867 shs$22.50 million07/08/2025$1.38$1.39+0.72%$1.42$1.37132,265 shs$22.34 million07/07/2025$1.40$1.38-1.43%$1.42$1.37176,804 shs$22.18 million07/04/2025$1.40$1.40$1.44$1.35141,523 shs$22.18 million07/03/2025$1.39$1.40+0.72%$1.44$1.35141,523 shs$22.50 million07/02/2025$1.40$1.39-0.71%$1.41$1.34140,355 shs$22.34 million07/01/2025$1.40$1.40$1.44$1.38330,929 shs$22.50 million Get the Latest News and Ratings for NNVC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter. 06/30/2025$1.40$1.40$1.40$1.32171,661 shs$22.50 million06/27/2025$1.23$1.40+13.82%$1.42$1.33625,726 shs$22.50 million06/26/2025$1.40$1.23-12.14%$1.40$1.15591,859 shs$19.77 million06/25/2025$1.40$1.40$1.46$1.35547,200 shs$22.50 million06/24/2025$1.37$1.40+2.19%$1.41$1.3795,352 shs$22.50 million06/23/2025$1.43$1.37-4.20%$1.45$1.36141,603 shs$22.02 million06/20/2025$1.34$1.43+6.72%$1.50$1.41308,120 shs$22.98 million06/19/2025$1.34$1.34$1.36$1.25121,624 shs$21.54 million06/18/2025$1.34$1.34$1.36$1.25121,624 shs$21.54 million06/17/2025$1.45$1.34-7.59%$1.46$1.33174,285 shs$21.54 million06/16/2025$1.51$1.45-3.97%$1.54$1.45224,625 shs$23.30 million06/13/2025$1.51$1.51$1.53$1.45304,393 shs$24.27 million Related Companies Invivyd Stock Price Chart Cellectis Stock Price Chart Adagene Stock Price Chart Oncolytics Biotech Stock Price Chart Climb Bio Stock Price Chart Elutia Stock Price Chart Entera Bio Stock Price Chart TScan Therapeutics Stock Price Chart eXoZymes Stock Price Chart Cabaletta Bio Stock Price Chart Receive NNVC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NNVC) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoViricides, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoViricides With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
